Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


First published on May 15, 2007
This version was published on July 1, 2007
Neuro Oncol 2007 9(3):326-334; DOI:10.1215/15228517-2007-005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
9/3/326    most recent
15228517-2007-005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holick, C. N.
Right arrow Articles by Michaud, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Clinical Investigations

Prospective study of cigarette smoking and adult glioma: Dosage, duration, and latency

Crystal N. Holick, Edward L. Giovannucci, Bernard Rosner, Meir J. Stampfer and Dominique S. Michaud

Departments of Nutrition (C.N.H., E.L.G., M.J.S.), Epidemiology (E.L.G., M.J.S., D.S.M.), and Biostatistics (B.R.), Harvard School of Public Health, Boston, MA 02115; and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital (E.L.G., B.R., M.J.S., D.S.M.), Harvard Medical School, Boston, MA 02115; USA

Address correspondence to Crystal N. Holick, Sc.D., MPH, Fred Hutchinson Cancer Center, 1100 Fairview Avenue North (M4-B402), Seattle, WA 98109, USA (cholick{at}fhcrc.org).

Tobacco products are major contributors of exogenous N-nitroso compounds, a group of potent neurocarcinogens. Overall results from studies of smoking and brain tumors have been null, but have provided little information on duration, age at smoking initiation, and latency. We prospectively examined the relation between cigarette smoking and glioma risk among men and women in three large U.S. cohort studies: the Health Professionals Follow-up Study (HPFS), the Nurses' Health Study I (NHS), and NHS II. Information on smoking history was obtained at baseline (1986 for HPFS, 1976 for NHS, and 1989 for NHS II) and updated biennially through 2002 in the HPFS and the NHS and 2003 in the NHS II. We confirmed 110 incident gliomas among men and 255 gliomas among women during 667,673 and 4,388,515 person-years of follow-up, respectively. Cox proportional hazard models were used to estimate incidence rate ratios and 95% confidence intervals between smoking and glioma risk adjusting for age, total meat intake, and alcohol and coffee consumption. Estimates from each cohort were pooled using a random-effects model after determining that there was no heterogeneity by sex. No association with glioma risk was observed between baseline or updated smoking status, intensity, duration, or age at smoking initiation among men and women. Furthermore, no association with glioma risk was observed after allowing for an induction period between smoking and glioma diagnosis. These findings provide strong evidence that cigarette smoking is not associated with an appreciably elevated risk of adult glioma.

Key Words: cigarette smoking • epidemiology • glioma • prospective studies







  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2007 by Society for Neuro-Oncology